Acute Kidney Injury Treatment Market Value to More than Double by 2029
Around 13 million caseloads of acute kidney injury (AKI) are registered annually. Alerted by the situation, regulatory bodies all over the world are significantly increasing healthcare spending in order to reach a larger patient base. Moreover, the healthcare industry is shifting towards a value-based model, which includes cost-containment, reimagining patient care delivery, and personalizing customer experience. As these trends that are driving the current surge in the healthcare vertical will persist, global revenue of the acute kidney injury treatment market will expand more than 2X by 2029.
Frequently Asked Questions about Acute Kidney Injury Treatment Market
Which region is expected to be at the forefront in terms of revenue in the global acute kidney injury treatment market?
North America is expected dominate the global acute kidney injury treatment market in terms of revenue, owing to rapid adoption of advanced treatment in the region. East Asia is expected to offer lucrative growth opportunities for the global acute kidney injury treatment market over the coming years.
Which product segment would be the most attractive for investments?
Dialysis gas emerged as the most attractive segment by product, owing to diverse device availability and efficient usage.
Which injury segment would be the most prominent during the forecast period?
The pre-renal injury segment is expected to be most prominent in the acute kidney injury treatment market, as it covers the maximum patient population.
Which distribution channel would contribute maximum revenue share during the forecast period?
Hospitals are expected to gain maximum share in the acute kidney injury treatment market, as governments in various countries are developing various platforms by creating more treatment options.
What strategies are prominent players in the acute kidney injury treatment market following?
New product development and subsequent launches are key strategies being followed by most manufacturers in global acute kidney injury treatment market.
What are impediments in the growth of the acute kidney injury treatment market?
Some of the prominent factors that might hamper the growth of the global acute kidney injury treatment market are lack of early disease detection and limited knowledge about kidney health. High cost associated with dialysis and long hospital stays are other factors projected to hamper the growth of the acute kidney injury treatment market over the forecast period.
Hospitals Capture Over Half of Total Market Stack
Capturing over 80% of total market stack, hospitals and ambulatory surgical centers (ASCs) continue to offer investment prospects to players in the acute kidney injury treatment market. While the adoption of AKI treatment in hospitals will enter the billion-dollar club in 2022, the same will happen in ASCs towards the end of the forecast period. Furthermore, hospitals are likely to strengthen their grip on market revenue in the near term, as governments in numerous countries are developing various platforms by creating more treatment options.
Developed Regions Maintain their Supremacy
North America and Europe have been the test bed for several tech-enabled transformations in the healthcare industry. Further, governments in these developed regions are allocating significant capital in order to offer enhanced healthcare delivery for catering to the expanding patient pool. Influenced by well-established healthcare infrastructure, players in the acute kidney injury treatment market would stick to these developed regional markets to ensure outsized returns in the coming years. This FMI report reveals that, the market in North America will expand nearly twice that of Europe by 2029.
Future Lies in Tech-driven AKI Treatment Devices
Conventional dialysis systems require manual adjustment of every parameter and human interference. With technology at the center, market players must develop automated, portable, and tech-driven dialysis equipment to deliver enhanced care to patients of every age group. These new-age dialysis machines enable the setting of disease parameters automatically, as well as minimize human intervention. Furthermore, players are focusing on improving the efficiency of dialysis, including the usage of high-flux and high-efficacy membranes, emanating from technical advances in polymer chemistry and membrane development.
High preference for dialysis
Drug therapy to lose traction
High adoption in treating pre-renal injury
Adoption in treating intrinsic renal injury to rise
Hospitals account for higher value share
Prevalence in ambulatory surgical centers to dip
How Growth will Unfold
Dialysis would remain the preferable procedure for treating acute kidney injury, with about 9 out of 10 healthcare professionals opting for this method. Under the treatment procedure, intermittent hemodialysis will lead the pack, owing to its excellent efficiency and rapid removal of drugs as compared to other dialysis methods. Such benefits of dialysis are influencing governments to establish greater number of dialysis centers. Dearth of available kidney donors, globally, is further driving the growth engine of the acute kidney injury treatment market.
* This data is only a representation. Actual data may vary and will be available in report.Click Here To Know How The Growth Will Unfold
Custom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
Acute Kidney Injury Treatment Market Analysis 2019-2029
A recent market study published by Future Market Insights (FMI) on the acute kidney injury treatment market includes global industry analysis of 2014-2018 and opportunity assessment for 2019-2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical as well as current growth parameters of the acute kidney injury treatment market, growth prospects are obtained with maximum precision.
Acute Kidney Injury Treatment Market Taxonomy
The global acute kidney injury treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the readers.
- Intermittent Hemodialysis
- Continuous Renal Replacement Therapy (CRRT)
- Sustained Low Efficiency Dialysis (SLED)
- Drug Therapy
- Immunosuppressive Agents
- Pre-renal Injury
- Intrinsic Renal Injury
- Post-renal Injury
- Ambulatory Surgical Centers
- North America
- South Asia
- East Asia
- Middle East & Africa
The report initiates with the executive summary of the acute kidney injury treatment market, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the acute kidney injury treatment market.
Readers can find the definition and a detailed segmentation of acute kidney injury treatment market in this chapter, which will help them understand the basic information about the market.
This chapter explains the key trends that are expected to influence the growth of the acute kidney injury treatment market during the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.
This section includes premium insights such as prevalence of various plant-related diseases, region-wise regulations for acute kidney injury treatment.
This section explains the global market value analysis and forecast for the acute kidney injury treatment during the forecast period. This chapter includes a detailed analysis of the historical acute kidney injury treatment
This section includes premium insights such as macroeconomic factors, drivers, opportunity and restraints.
Based on product, the acute kidney injury treatment market is segmented into Dialysis and Drug type. In this chapter, readers can find information about the key trends and developments in the acute kidney injury treatment and market attractiveness analysis based on product.
This chapter provides details about the acute kidney injury treatment market based on injury, and has been classified into Pre-renal Injury, Intrinsic Renal Injury and Post-renal Injury. In this chapter, readers can understand the market attractiveness analysis based on injury.
This chapter provides details about the acute kidney injury treatment market based on distribution channel, and has been classified into hospitals, ambulatory surgical centers and others. In this chapter, readers can understand the market attractiveness analysis based on distribution channel.
This chapter explains how the Acute Kidney Injury Treatment market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa (MEA).
This chapter includes a detailed analysis of growth of the North America acute kidney injury treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth and countries in North America.
This chapter provides the growth scenario of the acute kidney injury treatment market in Latin American countries such as Argentina, Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.
This chapter provides the growth scenario of the acute kidney injury treatment market in Europe in several countries such as Germany, the U.K., France, Spain, Italy, BENELUX, Russia and the Rest of Europe are included in this chapter.
This chapter provides the growth scenario of the acute kidney injury treatment market in East Asia in several countries such as China, Japan and South Korea are included in this chapter.
This chapter highlights the growth of the acute kidney injury treatment in South Asia by focusing on India, Thailand, Indonesia, Malaysia, rest of South Asia. This section also help readers understand the key factors that are responsible for the growth of the acute kidney injury treatment market in South Asia.
This chapter highlights the growth of the acute kidney injury treatment in Australia and New Zealand. This section also help readers understand the key factors that are responsible for the growth of the acute kidney injury treatment market in Oceania.
This chapter provides information about how the acute kidney injury treatment market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period.
In this chapter, readers can find tier wise contribution of key market players along with their company market share.
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the acute kidney injury treatment market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Merck & Co. Inc., Biocon Ltd., Teva Pharmaceutical Industries Ltd., Mylan N.V., Novartis AG, etc.
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the acute kidney injury treatment report.
This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the acute kidney injury treatment.
How the research was conducted?
- Marketing Directors
- Product Managers
- Business Development Officers
- Production Managers
- Sales Executives
- Industry Experts
- Current Market Dynamics and Challenges
- Yesteryear Trends
- Market Characteristics
- Market Performance and Growth Quadrants
- Strategic Growth Initiatives
- Near-term and Long-Term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
- Company Press Releases
- Annual Reports and Investor Presentations
- Research Papers
- Government Websites and Publications
Primary Interview Splits